Chylopericardium is the accumulation of chylous fluid in the pericardial space. Many etiologies can be found and the treatment depends on the etiology and remains unclear. This rare entity needs some tests to determine its causes. Diagnosis is based on many tools; the pericardial biopsy puncture and lymphoscintigraphy are the most important ones. The treatment requires low fat diet, lipid lowering therapy and surgery in some cases. We here report the first case in the IBN ROCHD university hospital's Cardiology department of Casablanca, Morocco. It deals with a 32-year-old patient who consulted for dyspnea exacerbation for 18 months, becoming at rest. Chest X-ray and echocardiography were performed discovering pericardial effusion. Pericardiocentesis was performed to confirm the nature of liquid and lymphoscintigraphy showed no abnormal communication between the thoracic duct and pericardium.
INTRODUCTION
Chylopericardium (CP) is accumulation of chylous fluid in the pericardial cavity [1] . It is considered idiopathic or primary when no etiology is found after investigations. The treatment often requires lipidlowering therapy and surgical drainage of the effusion. We report a 32-year-old man admitted in the IBN ROCHD University Hospital's cardiology department of Casablanca, for idiopathic chylopericardium.
CASE REPORT
A 32-year-old man was admitted with no cardiovascular risk factor of pericardial effusion, no sign of systemic disease, or past history of tuberculosis except for a thoracic trauma 3 years before with no complications. He complained dyspnea of NYHA class II, evolving for 18 months and decreasing at an anteflexed position. The worsening symptoms during the two last months led patient to seek medical consultation. Chest X-ray was performed showing cardiomegaly and echocardiography revealed liquid pericardial effusion of 16 mm in front of the right ventricle, 18 mm in front of the right atrium and 28 mm in front of the left ventricle without any sign of compression. His blood pressure was 120/80 mmHg and heart rate 95 Bpm. There was no jugular vein distension or other signs of tamponade.
ECG showed a sinus rhythm, with a low voltage and electrical alternans. Blood count, electrolytes, kidney function, and liver function tests had normal findings. Immunological assessment, thyroid function tests and tuberculosis had negative results. Lipid profile demonstrated cholesterol of 5.4mmol/l, triglycerides of 1.9mmol/l, low density lipoprotein (LDL)-cholesterol of 2.8 mmol/l and highdensity lipoprotein (HDL) -cholesterol of 1.4 mmol/l. A pericardial biopsy puncture was performed and 800 mL of thick milky chylous fluid was drained. The chylous nature of the fluid was confirmed by high level of triglycerides (10mmol/L) and a cholesteroltriglyceride ratio of 0.3 (below 1). Cytology demonstrated abundance of lymphocytes and no evidence of malignant cells. The culture for bacteria had negative result and anatomopathological study showed a chronic fibrous pericarditis with no sign of malignancy. A lymphoscintigraphy was performed, on a GE 630 Gamma Camera, to look for a breach in the thoracic duct or a communication with the pericardium. The protocol was a subcutaneous injection at the first interdigital space of each foot and each hand at rest of 90MBq Nancoll labeled with Tc 99m. It confirmed a normal lymphatic drainage in the upper and lower limbs with the absence of scintigraphic argument that may explain chylous pericardial effusion ( Fig 2) . The patient received lipid lowering treatment and antiinflammatory dosage of aspirin, colchicine 1mg for 6 months and assigned to low fat diet with no improvement. Therefore, an anti-bacillary treatment was started for 6 months, since the patient was in an endemic country for tuberculosis. 3 months later, the patient came back with recurrence of the pericardial effusion without any sign of compression or tamponade. The inferior vena cava measured 21 mm. Therefore, the patient was candidate for a pleuro-pericardial window with a favorable evolution for 3 months till writing the manuscript. 
DISCUSSION
Chylopericardium is an abnormal accumulation of chylous fluid containing triglycerides in high concentrations in the pericardium [2] . It is still a rare form of pericardial effusion. Only few cases are described in literature; the first one was by Hasebrock in 1888 [3] and then it was reviewed in other studies. [6] . CP occurs in all ages more dominantly in children and young adults [1] . The mean age in C. Dib study was about 36.78 ± 14.71 years with no gender specificity [1, 2] and 27.95 ± 16.50 years in Yu et al. study with 5 cases younger than 3 years [6] . The disease can be diagnosed in asymptomatic patients referred for annual health examination showing a cardiomegaly or detected by dyspnea, chest pain or cough [1] . Cardiac tamponade is rare. Most common etiologies are congenital mediastinal lymphangiectasia, iatrogenic after cardiac surgery, malignant tumors especially mediastinal ones, Gorham syndrome (defined by osteolysis resulting from lymphangiomatosis with adjacent bone resorption), blunt or penetrating trauma, infection or radiation or congenital lymphatic anomalies. Primary or idiopathic CP is known as a less common cause [1, 7, 8] . Idiopathic CP is an exclusion diagnosis when no etiology is found. This has different possible explanations proposed by Dunn and reviewed by Yu: a) Function default of lymphatic valves that are connected to the thoracic duct and pericardium lymphatic vessel; b) lymphangectasia caused by elevated pressure in the thoracic duct; c) abnormal communication between the lymphatic vessel and the pericardial sac resulting in chylous reflux; d) congenital malformation [6] . The diagnostic is usually confirmed by pericardiocentesis, followed by cytology, chemistry and culture. The fluid analysis shows a whitish or milky liquid with a high triglyceride and protein content, a predominance of lymphocytes and the presence of fat globules by Sudan III staining (on garde ou pas). Blood cultures had universally negative results [2] . A scoring system has been proposed by Dib et al. [2] to help establishing the diagnosis of CP. It is calculated according to the following features: i) Milky yellowish appearance of fluid; ii) TG level of >500 mg/dL; iii) Total Cholesterol/TG ratio of below 1; and iv) negative results for fluid bacterial culture and lymphocytic predominance on fluid cell count. Each feature is given 1 point and a score of 2 (specificity and sensitivity of 100%) is required for the diagnosis of CP. Several modalities of etiological diagnosis have been reported, but lymphangiography or lymphoscintigraphy are the most used tests to detect an abnormal connection between the thoracic duct and the pericardium [1] . Lymphangiography is an invasive method including direct administration of contrast agent into cannulated lymph vessels. Combining lymphangiography and CT can be useful to detect lymphatic vessels and their relationships with the pericardial cavity.
In the other hand, Lymphoscintigraphy uses radionuclides as contrast agent. It can be an alternative to lymphangiography as it is a less invasive and faster procedure. In Yu et al. study, 42 (40.38%) cases underwent lymphangioscintigraphy and 24 of them had abnormal accumulation within the pericardial sac. Among 24 cases of their series who underwent lymphangiography, 18 had abnormal findings [6] . In our study, there was no abnormal communication between the thoracic duct and pericardium. Optimal treatment for primary CP is still not well established. The current options are either conservative therapy including total parenteral nutrition, a low-fat diet with medium-chain triglycerides or surgical approach. The conservative one is known to be successful in post-traumatic CP [9] . It can be tried, especially if the patient is reluctant to undergo surgery or has concomitant life-limiting disease but it often fails [2] . Surgical treatment can be either a pericardiectomy, to ensure complete drainage and to prevent secondary constrictive pericarditis, or creation of a pericardial window. The latter is insufficient since it has a high recurrence rate and it does not close the communication between the thoracic duct and the pericardial sac. Ligation of the thoracic duct above the level of the diaphragm remains the best choice. Video-assisted thoracoscopic surgery is also becoming more favorable by cardiothoracic surgeons, since it is less invasive and affects the pulmonary function to a lesser extent. Furthermore, embolism of the thoracic duct is used in certain situation, and it is an alternative type of surgery, particularly for patients who refuse to be subjected or re-subjected to more invasive approaches or those who cannot tolerate anesthesia [6] .
CONCLUSIONS
Although chylopericardium is an uncommon cause of pericardial effusion, clinicians should keep this diagnosis in mind in pericarditis. Pericardiocentesis is the best way to analyze the liquid nature and help to determine the etiology. Even though, many causes can be found after investigations, idiopathic or primary CP is still a rare condition with only around 100 cases reported worldwide to date, and even less in Morocco.
